(Q51861083)

14 April 2018

title

Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia. (English)

1 reference

14 April 2018

0 references

1 reference

2

1 reference

14 April 2018

Ole A. Andreassen

10

1 reference

14 April 2018

Stein Opjordsmoen Ilner

8

object named as

S Opjordsmoen

1 reference

14 April 2018

9

I Melle

1 reference

14 April 2018

3

K Sundet

1 reference

14 April 2018

7

S Friis

1 reference

14 April 2018

P A Ringen

1

1 reference

14 April 2018

J A Engh

4

1 reference

14 April 2018

H Jónsdóttir

5

1 reference

14 April 2018

C Simonsen

6

1 reference

14 April 2018

language of work or name

English

0 references

publication date

6 November 2009

1 reference

14 April 2018

published in

Psychological Medicine

1 reference

14 April 2018

volume

40

1 reference

14 April 2018

issue

8

1 reference

14 April 2018

page(s)

1337-1347

1 reference

14 April 2018

Neurocognitive profiles in bipolar I and bipolar II disorder: differences in pattern and magnitude of dysfunction

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

The continuum of psychosis and its implication for the structure of the gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Iowa gambling task in schizophrenia: a review and new data in patients with schizophrenia and co-occurring cannabis use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

The neuropsychological correlates of cannabis use in schizophrenia: lifetime abuse/dependence, frequency of use, and recency of use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

The acute effects of cannabinoids on memory in humans: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

The prevalence and significance of substance use disorders in bipolar type I and II disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Correlates of substance use disorder among psychiatric outpatients: focus on cognition, social role functioning, and psychiatric status

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Generalizability studies of the Global Assessment of Functioning-Split version.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Measurement of premorbid adjustment in chronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Cognitive compromise in bipolar disorder with chronic cannabis use: cause or consequence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Identification of loci associated with schizophrenia by genome-wide association and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Accuracy of self-reported premorbid functioning in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Functional outcome in bipolar disorder: the role of clinical and cognitive factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Premorbid adjustment in first-episode non-affective psychosis: distinct patterns of pre-onset course.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Baseline neurocognitive deficits in the CATIE schizophrenia trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Comparing genes and phenomenology in the major psychoses: schizophrenia and bipolar 1 disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Effects of marijuana on neurophysiological signals of working and episodic memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Brain activation measured with fMRI during a mental arithmetic task in schizophrenia and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Neurocognitive functioning and quality of life among dually diagnosed and non-substance abusing schizophrenia inpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Cannabis use and expression of mania in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Illicit drug use in patients with psychotic disorders compared with that in the general population: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Cannabis use and misuse prevalence among people with psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

The endophenotype concept in psychiatry: etymology and strategic intentions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Anxiety and cognitive performance: attentional control theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Specificity of cognitive deficits in bipolar disorder versus schizophrenia. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Response inhibition and cognitive flexibility in schizophrenia with and without comorbid substance use disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

The ʻbig bangʼ theory of the origin of psychosis and the faculty of language

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Drug abuse and/or dependence and better neuropsychological performance in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

inferred from DOI database lookup

7 January 2021

based on heuristic

Validity of substance use self-reports in dually diagnosed outpatients

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

inferred from DOI database lookup

7 January 2021

based on heuristic

Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991620

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1017/S0033291709991620

1 reference

14 April 2018

1 reference

14 April 2018